Publications (original articles or review articles) published in 2013 from OUS - Section for Cellular Therapy
16 publications found
Mutation spectrum in South American Lynch syndrome families
Hered Cancer Clin Pract, 11 (1), 18
DOI 10.1186/1897-4287-11-18, PubMed 24344984
The ex vivo induction of human CD103⁺ CD25hi Foxp3⁺ CD4⁺ and CD8⁺ Tregs is IL-2 and TGF-β1 dependent
Scand J Immunol, 77 (2), 125-34
DOI 10.1111/sji.12009, PubMed 23126599
A synthetic codon-optimized hepatitis C virus nonstructural 5A DNA vaccine primes polyfunctional CD8+ T cell responses in wild-type and NS5A-transgenic mice
J Immunol, 190 (3), 1113-24
DOI 10.4049/jimmunol.1201497, PubMed 23284053
3',4'-Dimethoxyflavone and valproic acid promotes the proliferation of human hematopoietic stem cells
Stem Cell Res Ther, 4 (3), 60
DOI 10.1186/scrt208, PubMed 23706670
The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon
PLoS One, 8 (6), e65964
DOI 10.1371/journal.pone.0065964, PubMed 23785460
Blocking mtDNA replication upregulates the expression of stemness-related genes in prostate cancer cell lines
Ultrastruct Pathol, 37 (4), 258-66
DOI 10.3109/01913123.2013.770112, PubMed 23634795
SHBG is an important factor in stemness induction of cells by DHT in vitro and associated with poor clinical features of prostate carcinomas
PLoS One, 8 (7), e70558 (Retracted)
DOI 10.1371/journal.pone.0070558, PubMed 23936228
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
Leukemia, 27 (7), 1520-6
DOI 10.1038/leu.2013.19, PubMed 23328954
Selective inhibition of cell death in malignant vs normal B-cell precursors: implications for cAMP in development and treatment of BCP-ALL
Blood, 121 (10), 1805-13
DOI 10.1182/blood-2012-08-452698, PubMed 23299313
Nanometric protein-patch arrays on glass and polydimethylsiloxane for cell adhesion studies
Nano Lett, 13 (7), 3372-8
DOI 10.1021/nl401696m, PubMed 23808889
Clinical significance of disseminated tumour cells in non-small cell lung cancer
Br J Cancer, 109 (5), 1264-70
DOI 10.1038/bjc.2013.450, PubMed 23942067
Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients
Int J Oncol, 43 (1), 280-8
DOI 10.3892/ijo.2013.1922, PubMed 23620105
A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells
FASEB J, 27 (8), 3272-83
DOI 10.1096/fj.12-224758, PubMed 23671272
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
Cancer Immunol Immunother, 62 (9), 1499-509
DOI 10.1007/s00262-013-1453-3, PubMed 23817721
Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines
PLoS One, 8 (3), e57020 (Retracted)
DOI 10.1371/journal.pone.0057020, PubMed 23469181
In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines
Exp Hematol Oncol, 2 (1), 16
DOI 10.1186/2162-3619-2-16, PubMed 23738757